Search
Categories
Hot topics close

Biogen to halt late-stage trial of promising Alzheimer's drug

US pharmaceuticals company Biogen and its Japanese partner Eisai have announced they will cease clinical trials for a promising Alzheimer's disease treatment, sending shares in Biogen tumbling by a quarter. Nasdaq-listed Biogen and Tokyo-listed Eisai 
Similar news
News Archive
  • Volume
    Volume
    Cindicator One Day Trading Volume Hits $522,338.00 (CND)
    3 Jul 2019
    2
  • Nadia Toffa
    Nadia Toffa
    Nadia Toffa is dead after cancer battle - English
    13 Aug 2019
    2
  • Kew Gardens
    Kew Gardens
    Rare Kew Gardens 50p coin sells for £171 on eBay – how to spot one in your change...
    15 Dec 2021
    2
  • Chris Smalling
    Chris Smalling
    Roma star Chris Smalling praised for 'man of the match' outing in Europa Conference League final
    25 May 2022
    14
  • Symptom
    Symptom
    Long covid symptoms may include hair loss and ejaculation difficulties
    26 Jul 2022
    3
This week's most popular news